Lee Kalowski

Lee Kalowski

No más puestos en curso

Fortuna: 2 M $ al 31/08/2026

45 años
Health Technology
Finance
Consumer Services

Perfil

Lee H.
Kalowski
is President & Chief Financial Officer at Q32 Bio, Inc. since 2024.
Formerly, Mr. Kalowski was President & Chief Financial Officer at Bicycle Therapeutics Plc from 2019 to 2023, Chief Financial Officer at Tokai Pharmaceuticals, Inc. from 2014 to 2016, Research Analyst at Sanford C.
Bernstein & Co. LLC from 2007 to 2008, Research Analyst at Prudential Equity Group LLC from 2005 to 2007, and held positions at Credit Suisse Securities (USA) LLC (Broker), Eledon Pharmaceuticals, Inc., and Bicycle Therapeutics, Inc. Education includes an undergraduate degree from Union College (New York) in 2003 and an MBA from The Wharton School of the University of Pennsylvania in 2010.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
0,47 %
25/08/2026 138.471 ( 0,47 % ) 2 M $ 31/08/2026

Cargos activos de Lee Kalowski

EmpresasCargoInicio

Antiguos cargos conocidos de Lee Kalowski.

EmpresasCargoFin
Director Financiero/CFO 22/06/2023
BICYCLE THERAPEUTICS PLC Presidente 22/06/2023
Director Financiero/CFO 31/08/2016
ELEDON PHARMACEUTICALS, INC. Director Financiero/CFO 01/08/2016
Analyst-Equity -
Ver el detalle de la experiencia de Lee Kalowski.

Formación de Lee Kalowski.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

90

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Finance

Finance

Consumer Services

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology